FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:635 August 28, 1997 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Connolly, H. M. PubMed Citation

To the Editor: In this issue of the Journal is a report of 24 cases of valvular heart disease in women treated with a combination of fenfluramine and phentermine.¹ On the basis of prepublication notification of this finding, the Food and Drug Administration issued a Public Health Advisory on July 8 in which it requested that other cases be reported. We now describe an additional 28 patients from the United States with similar disease. Excluded from this series were a handful of reports describing isolated tricuspid insufficiency in the presence of primary pulmonary hypertension or isolated mitral-valve prolapse.

The reports . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148 [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: 598-675 [Full Text]  
• Lynch, M. J., Burns, R. G., Holcomb, J. E. (2005). Food for Thought: An Investigation of Food and Drug Administration Reporting Practices, 1995-1999. Criminal Justice Review 30: 293-311 [Abstract]  
• Wysowski, D. K., Swartz, L. (2005). Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002: The Importance of Reporting Suspected Reactions. Arch Intern Med 165: 1363-1369 [Abstract] [Full Text]  
• Elangbam, C. S., Lightfoot, R. M., Yoon, L. W., Creech, D. R., Geske, R. S., Crumbley, C. W., Gates, L. D., Wall, H. G. (2005). 5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats. J. Histochem. Cytochem. 53: 671-677 [Abstract] [Full Text]  
• Elangbam, C. S., Colman, K. A., Lightfoot, R. M., Tyler, R. D., Wall, H. G. (2002). Endocardial Myxomatous Change in Harlan Sprague-Dawley Rats (Hsd:S--D) and CD-1 Mice: Its Microscopic Resemblance to Drug-Induced Valvulopathy in Humans. Toxicol Pathol 30: 483-491 [Abstract]  
• Belohlavkova, S., Simak, J., Kokesova, A., Hnilickova, O., Hampl, V. (2001). Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. J. Appl. Physiol. 91: 755-761 [Abstract] [Full Text]  
• Gardin, J. M., Schumacher, D., Constantine, G., Davis, K. D., Leung, C., Reid, C. L. (2000). Valvular Abnormalities and Cardiovascular Status Following Exposure to Dexfenfluramine or Phentermine/Fenfluramine. JAMA 283: 1703-1709 [Abstract] [Full Text]  
• Jick, H. (2000). Heart Valve Disorders and Appetite-Suppressant Drugs. JAMA 283: 1738-1740 [Full Text]  
• Bray, G. A., Greenway, F. L. (1999). Current and Potential Drugs for Treatment of Obesity. Endocr. Rev. 20: 805-875 [Abstract] [Full Text]  
• Shively, B. K., Roldan, C. A., Gill, E. A., Najarian, T., Loar, S. B. (1999). Prevalence and Determinants of Valvulopathy in Patients Treated With Dexfenfluramine. Circulation 100: 2161-2167 [Abstract] [Full Text]  
• Wood, A. J. J. (1999). The Safety of New Medicines: The Importance of Asking the Right Questions. JAMA 281: 1753-1754 [Full Text]  
• Tovar, E. A., Landa, D. W., Borsari, B. E. (1999). Dose effect of fenfluramine-phentermine in the production of valvular heart disease. Ann. Thorac. Surg. 67: 1213-1214 [Full Text]  
• Brewer, T., Colditz, G. A. (1999). Postmarketing Surveillance and Adverse Drug Reactions: Current Perspectives and Future Needs. JAMA 281: 824-829 [Abstract] [Full Text]  
• Fishman, A. P. (1999). Aminorex to Fen/Phen : An Epidemic Foretold. Circulation 99: 156-161 [Full Text]  
• Hu, S., Wang, S., Gibson, J., Gilbertson, T. A. (1998). Inhibition of Delayed Rectifier K+ Channels by Dexfenfluramine (Redux). J. Pharmacol. Exp. Ther. 287: 480-486 [Abstract] [Full Text]  
• Jick, H., Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., Derby, L. E. (1998). A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation. NEJM 339: 719-724 [Abstract] [Full Text]  
• Mulrow, C. D (1998). Evidence based case report: Helping an obese patient make informed choices. BMJ 317: 266-267 [Full Text]  
• Kassirer, J. P., Angell, M. (1998). Losing Weight -- An Ill-Fated New Year's Resolution. NEJM 338: 52-54 [Full Text]  
• (1997). MORE ON DIET PILLS AND VALVULAR DISEASE. JWatch General 1997: 1-1 [Full Text]  
• Curfman, G. D. (1997). Diet Pills Redux. NEJM 337: 629-630 [Full Text]